| Safety and immunogenicity of SpikoGen®, an Advax-CpG55. 2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and … P Tabarsi, N Anjidani, R Shahpari, M Mardani, A Sabzvari, B Yazdani, ... Clinical Microbiology and Infection 28 (9), 1263-1271, 2022 | 42 | 2022 |
| Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis S Rezaei, B Fatemi, Z Karimi Majd, H Minaei, M Peikanpour, N Anjidani, ... Expert review of clinical immunology 17 (5), 499-511, 2021 | 35 | 2021 |
| Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55. 2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized … P Tabarsi, N Anjidani, R Shahpari, M Mardani, A Sabzvari, B Yazdani, ... Clinical Microbiology and Infection 29 (2), 215-220, 2023 | 30 | 2023 |
| A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury A Taheri, M Emami, E Asadipour, S Kasirzadeh, MR Rouini, A Najafi, ... Journal of neurology 266, 1988-1997, 2019 | 28 | 2019 |
| β-Sitosterol Alters the Inflammatory Response in CLP Rat Model of Sepsis by Modulation of NFκB Signaling S Kasirzadeh, MH Ghahremani, N Setayesh, F Jeivad, A Shadboorestan, ... BioMed research international 2021, 2021 | 24 | 2021 |
| Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study A Taheri, H Lavasani, S Kasirzadeh, B Sheikholeslami, YH Ardakani, ... Xenobiotica 48 (10), 984-989, 2018 | 13 | 2018 |
| Battle of the milky way: Lymphatic targeted drug delivery for pathogen eradication A Taheri, KE Bremmell, P Joyce, CA Prestidge Journal of Controlled Release 363, 507-524, 2023 | 3 | 2023 |
| Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis S Rezaei, A Taheri, S Taheri, S Kasirzadeh, B Fatemi, MM Sorato Expert Review of Clinical Pharmacology 15 (6), 767-777, 2022 | 2 | 2022 |
Rouini MRProfessor of Biopharmaceutics and pharmacokinetics, Tehran university of Medical Sciences, Faculty of PharmacyVerified email at tums.ac.ir
